337 related articles for article (PubMed ID: 19966290)
21. AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling.
Sherman MH; Kuraishy AI; Deshpande C; Hong JS; Cacalano NA; Gatti RA; Manis JP; Damore MA; Pellegrini M; Teitell MA
Mol Cell; 2010 Sep; 39(6):873-85. PubMed ID: 20864035
[TBL] [Abstract][Full Text] [Related]
22. Chimeric IgH-TCRalpha/delta translocations in T lymphocytes mediated by RAG.
Callén E; Bunting S; Huang CY; Difilippantonio MJ; Wong N; Khor B; Mahowald G; Kruhlak MJ; Ried T; Sleckman BP; Nussenzweig A
Cell Cycle; 2009 Aug; 8(15):2408-12. PubMed ID: 19556863
[TBL] [Abstract][Full Text] [Related]
23. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
[TBL] [Abstract][Full Text] [Related]
24. Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
Chen Z; Elos MT; Viboolsittiseri SS; Gowan K; Leach SM; Rice M; Eder MD; Jones K; Wang JH
J Hematol Oncol; 2016 Jan; 9():2. PubMed ID: 26740101
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation.
Dorsett Y; McBride KM; Jankovic M; Gazumyan A; Thai TH; Robbiani DF; Di Virgilio M; Reina San-Martin B; Heidkamp G; Schwickert TA; Eisenreich T; Rajewsky K; Nussenzweig MC
Immunity; 2008 May; 28(5):630-8. PubMed ID: 18455451
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms that can promote peripheral B-cell lymphoma in ATM-deficient mice.
Tepsuporn S; Hu J; Gostissa M; Alt FW
Cancer Immunol Res; 2014 Sep; 2(9):857-66. PubMed ID: 24913718
[TBL] [Abstract][Full Text] [Related]
27. AID induces double-strand breaks at immunoglobulin switch regions and c-MYC causing chromosomal translocations in yeast THO mutants.
Ruiz JF; Gómez-González B; Aguilera A
PLoS Genet; 2011 Feb; 7(2):e1002009. PubMed ID: 21383964
[TBL] [Abstract][Full Text] [Related]
28. Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
Casellas R; Yamane A; Kovalchuk AL; Potter M
Immunology; 2009 Mar; 126(3):316-28. PubMed ID: 19302140
[TBL] [Abstract][Full Text] [Related]
29. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations.
Franco S; Gostissa M; Zha S; Lombard DB; Murphy MM; Zarrin AA; Yan C; Tepsuporn S; Morales JC; Adams MM; Lou Z; Bassing CH; Manis JP; Chen J; Carpenter PB; Alt FW
Mol Cell; 2006 Jan; 21(2):201-14. PubMed ID: 16427010
[TBL] [Abstract][Full Text] [Related]
30. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
Pérez-Durán P; de Yebenes VG; Ramiro AR
Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
[TBL] [Abstract][Full Text] [Related]
32. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development.
Takizawa M; Tolarová H; Li Z; Dubois W; Lim S; Callen E; Franco S; Mosaico M; Feigenbaum L; Alt FW; Nussenzweig A; Potter M; Casellas R
J Exp Med; 2008 Sep; 205(9):1949-57. PubMed ID: 18678733
[TBL] [Abstract][Full Text] [Related]
33. Regulation of activity and function of the p52 NF-κB subunit following DNA damage.
Barré B; Coqueret O; Perkins ND
Cell Cycle; 2010 Dec; 9(24):4795-804. PubMed ID: 21131783
[TBL] [Abstract][Full Text] [Related]
34. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
35. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
[TBL] [Abstract][Full Text] [Related]
36. The RAG2 C terminus suppresses genomic instability and lymphomagenesis.
Deriano L; Chaumeil J; Coussens M; Multani A; Chou Y; Alekseyenko AV; Chang S; Skok JA; Roth DB
Nature; 2011 Mar; 471(7336):119-23. PubMed ID: 21368836
[TBL] [Abstract][Full Text] [Related]
37. Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.
Sernández IV; de Yébenes VG; Dorsett Y; Ramiro AR
PLoS One; 2008; 3(12):e3927. PubMed ID: 19079594
[TBL] [Abstract][Full Text] [Related]
38. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
Yan Y; Park SS; Janz S; Eckhardt LA
Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
[TBL] [Abstract][Full Text] [Related]
39. Translocation of an antibody transgene requires AID and occurs by interchromosomal switching to all switch regions except the mu switch region.
Shansab M; Eccleston JM; Selsing E
Eur J Immunol; 2011 May; 41(5):1456-64. PubMed ID: 21469111
[TBL] [Abstract][Full Text] [Related]
40. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas.
Hallermann C; Kaune KM; Gesk S; Martin-Subero JI; Gunawan B; Griesinger F; Vermeer MH; Santucci M; Pimpinelli N; Willemze R; Siebert R; Neumann C
J Invest Dermatol; 2004 Jul; 123(1):213-9. PubMed ID: 15191563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
